Edition:
United States

TG Therapeutics Inc (TGTX.OQ)

TGTX.OQ on NASDAQ Stock Exchange Capital Market

4.52USD
18 Jan 2019
Change (% chg)

$0.10 (+2.26%)
Prev Close
$4.42
Open
$4.42
Day's High
$4.59
Day's Low
$4.40
Volume
300,807
Avg. Vol
451,833
52-wk High
$17.30
52-wk Low
$3.41

Chart for

About

TG Therapeutics, Inc. (TG) is a biopharmaceutical company focused on the acquisition, development and commercialization of treatments for B-cell malignancies and autoimmune diseases. As of December 31, 2016, the Company was developing two therapies targeting hematological malignancies. TG-1101 (ublituximab) is a glycoengineered... (more)

Overall

Beta: 1.66
Market Cap(Mil.): $407.85
Shares Outstanding(Mil.): 82.90
Dividend: --
Yield (%): --

Financials

  TGTX.OQ Industry Sector
P/E (TTM): -- 95.96 30.88
EPS (TTM): -2.08 -- --
ROI: -192.77 0.60 13.80
ROE: -198.93 -2.18 15.29

Earnings vs. Estimates